Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment

• Status: Completed
• Trial end date: 2010-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study was to measure the effect of low- and high-dose lipid-lowering treatment with rosuvastatin on the coronary physiology parameters.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Odense University Hospital
• Treatments: Rosuvastatin Calcium

Criteria

Inclusion Criteria:

1. ST-segment elevation myocardial infarction

2. no prior treatment with statins and

3. a non significant lesion in one of the two non-culprit coronary arteries

Exclusion Criteria:

1. age below 18 or above 81 years,

2. unconscious patients,

3. serum creatinine > 176μmol/L,

4. hypothyroidism ((TSH > 1.5 x ULN (upper limit of normal)),

5. current liver disease (ALAT > 2 x ULN),

6. unexplained creatine kinase > 3 x ULN,

7. alcohol or drug abuse within the last five years,

8. prior myopathy or serious hypersensitivity reaction caused by statins,

9. women with childbearing potential who were not using chemical or mechanical contraception,

10. pregnant or breastfeeding women,

11. history of malignancy unless a disease-free period of more than five years was present,

12. patients with abnormal lung function test (LFT),

13. participation in another investigational drug study less than four weeks before enrolment in the present study,

14. treatment with cyclosporine or fibrates